Jeff Schell, founded Rocky Mountain Patent and the Quandary Group with a talented team of scientists, engineers and attorneys on a mission to transform innovative concepts into companies. He then leveraged the valuable IP the group developed to raise several million dollars to acquire medical device company TranS1’s IP assets. Within a few years of rebuilding TranS1 as CEO, ColoradoBiz Magazine named TranS1 one of the top 250 companies in Colorado by revenue. The Denver Post also named TranS1 Denver’s “Most Innovative Workplace” in 2016. Further, the Colorado Technology Association named TranS1 a nominee for “Company of the Year.” Under Jeff’s leadership, Orthopedics This Week awarded TranS1 with the 2017 Spine Technology Award. In addition to building intellectual property strategies with the Rocky Mountain Patent team, Jeff now advises, operates and invests in multiple companies.